Literature DB >> 8082717

Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro.

P W Sylvester1, H P Birkenfeld, H L Hosick, K P Briski.   

Abstract

Mammary epithelial cells were isolated from midpregnant BALB/c mice, grown in primary culture within collagen gels, and maintained with serum-free medium containing 10 ng/ml epidermal growth factor (EGF) as the mitogen. Supplementation of culture medium with the saturated fatty acid, Na-stearate (18:0), significantly attenuated, whereas treatment with the unsaturated fatty acid, Na-arachidonate (20:4), significantly enhanced mammary epithelial cell proliferation, as compared to untreated controls. Treatment with various doses of either 18:0 or 20:4 was also found to result in a direct dose-dependent enrichment of mammary epithelial cell membrane fatty acid composition and a concurrent decrease in the relative levels of other membrane fatty acids, as determined by gas chromatography. Administration of the prostaglandin synthesis inhibitor, indomethacin, significantly inhibited EGF-induced cell growth in all treatment groups, but did not alter the relative inhibitory (18:0) or stimulatory (20:4) effects of fatty acid treatment. EGF-induced PKC translocation into the membrane fraction of mammary epithelial cells was enhanced in 20:4 and attenuated in 18:0 treatment groups, as compared to controls. Western blot analysis of phospholipid-dependent protein kinase C isoenzymes showed that PKC alpha was the predominant isoenzyme present in mouse mammary epithelial cells grown in primary culture, and the molecular weight of this PKC isoenzyme was determined to be 85 kDa. These results suggest that supplementation of culture media with specific fatty acids is associated with significant alterations in mammary epithelial cell membrane fatty acid composition, PKC activation, and mitogenic responsiveness. Since EGF can induce both PKC activation and cell proliferation, and because PKC activation requires membrane-derived phospholipids and diacylglycerol, these data suggest that specific fatty acid modulation of mammary epithelial cell mitogenesis is mediated through alterations in PKC alpha activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082717     DOI: 10.1006/excr.1994.1243

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

1.  Immortalization of mammary cells from estrogen receptor alpha knock-out and wild-type mice.

Authors:  S O Mueller; H Tahara; J C Barrett; K S Korach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

2.  Processing and characterization of porous alumina scaffolds.

Authors:  Susmita Bose; Jens Darsell; Howard L Hosick; Lihua Yang; Dipak K Sarkar; Amit Bandyopadhyay
Journal:  J Mater Sci Mater Med       Date:  2002-01       Impact factor: 3.896

3.  Effects of ultra-wideband electromagnetic pulses on pre-neoplastic mammary epithelial cell proliferation.

Authors:  P W Sylvester; S J Shah; D T Haynie; K P Briski
Journal:  Cell Prolif       Date:  2005-06       Impact factor: 6.831

4.  Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation.

Authors:  P W Sylvester; B S McIntyre; A Gapor; K P Briski
Journal:  Cell Prolif       Date:  2001-12       Impact factor: 6.831

5.  Activation of Raf-1 during experimental gastric ulcer healing is Ras-mediated and protein kinase C-independent.

Authors:  R Pai; M K Jones; M Tomikawa; A S Tarnawski
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 6.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

7.  Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.

Authors:  Vikram B Wali; Sunitha V Bachawal; Paul W Sylvester
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

8.  Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.

Authors:  Sunitha V Bachawal; Vikram B Wali; Paul W Sylvester
Journal:  BMC Cancer       Date:  2010-03-08       Impact factor: 4.430

9.  Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression.

Authors:  G V Samant; V B Wali; P W Sylvester
Journal:  Cell Prolif       Date:  2009-11-17       Impact factor: 6.831

10.  Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.

Authors:  Vikram B Wali; Paul W Sylvester
Journal:  Lipids       Date:  2007-08-14       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.